Sorry, you need to enable JavaScript to visit this website.
Skip to main content
  • News
    • Press Releases
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • Compliance & Transparency
  • Contact Us
    • Our Locations
    • Medical Information
  • Country List
SEARCH
Home

Main navigation

  • Our Company
    • About Incyte The Netherlands
    • Our Team
  • What We Do
    • Global Portfolio
    • Hematology and Oncology
    • Inflammation and Autoimmunity
    • Our Medicines
    • Partnerships
  • Culture & Careers
  • Materiaal voor Patiënten
  • HCP Resources
  1. Home
  2. What We Do
  3. Our Medicines
  • SEARCH
  • Our Company
    • About Incyte The Netherlands
    • Our Team
  • What We Do
    • Global Portfolio
    • Hematology and Oncology
    • Inflammation and Autoimmunity
    • Our Medicines
    • Partnerships
  • Culture & Careers
  • Materiaal voor Patiënten
  • HCP Resources
  • News
    • Press Releases
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • Compliance & Transparency
  • Contact Us
    • Our Locations
    • Medical Information
  • United States

INCYTE AROUND THE WORLD

GLOBAL HEADQUARTERS

DENMARK

ITALY

PORTUGAL

UNITED KINGDOM

AUSTRIA

FINLAND

JAPAN

SPAIN

BELGIUM

FRANCE

THE NETHERLANDS

SWEDEN

CANADA

GERMANY

NORWAY

SWITZERLAND

Close

Our Licensed Medicines
Our Licensed Medicines
Our Licensed Medicines

Our Licensed Medicines

  • Hematology and Oncology Therapies

Iclusig® (ponatinib)

Learn More >

Minjuvi® (tafasitamab)

Learn More >

Pemazyre® (pemigatinib)

Learn More >

Zynyz® (retifanlimab)

Learn More >

  • Inflammation and Autoimmunity Therapies

Opzelura® (ruxolitinib) cream

Learn More >

Our Global Portfolio

HCP Resources

Footer Logo 
  • LinkedIn Icon
  • Twitter Icon
  • Instagram Icon
  • Facebook Icon
  • Youtube Icon
  • Our Company
    • About Incyte The Netherlands
    • Our Team
  • What We Do
    • Global Portfolio
    • Hematology and Oncology
    • Inflammation and Autoimmunity
    • Our Medicines
    • Partnerships
  • Culture & Careers
  • Materiaal voor Patiënten
  • HCP Resources
  • News
    • Press Releases
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • Compliance & Transparency
  • Contact Us
    • Our Locations
    • Medical Information
  • Legal Notice
  • Suppliers
  • Site Map
  • Privacy Policy
  • Cookie Policy
April 2026 NL/CORP/NP/26/0001 © 2012-2026 Incyte.